Objective: We investigated the association between 52 risk variants identified through genome-wide association studies and disease severity in multiple sclerosis (MS). Methods: Ten unique MS case data sets were analyzed. The Multiple Sclerosis Severity Score (MSSS) was calculated using the Expanded Disability Status Scale at study entry and disease duration. MSSS was considered as a continuous variable and as 2 dichotomous variables (median and extreme ends; MSSS of ≤5 vs >5 and MSSS o
Background: Multiple sclerosis (MS) is the most common cause of chronic neurologic disability beginn...
Using the ImmunoChip custom genotyping array, we analyzed 14,498 subjects with multiple sclerosis an...
Using the ImmunoChip custom genotyping array, we analyzed 14,498 subjects with multiple sclerosis an...
We investigated the association between 52 risk variants identified through genome-wide association ...
We investigated the association between 52 risk variants identified through genome-wide association ...
ObjectiveWe investigated the association between 52 risk variants identified through genome-wide ass...
OBJECTIVE: We investigated the association between 52 risk variants identified through genome-wide ...
A recent genome wide association study (GWAS) demonstrated that more than 100 genetic variants influ...
A recent genome wide association study (GWAS) demonstrated that more than 100 genetic variants influ...
A previous study using cumulative genetic risk estimations in multiple sclerosis (MS) successfully t...
A previous study using cumulative genetic risk estimations in multiple sclerosis (MS) successfully t...
Using the ImmunoChip custom genotyping array, we analyzed 14,498 subjects with multiple sclerosis an...
Background: Multiple sclerosis (MS) is the most common cause of chronic neurologic disability beginn...
Using the ImmunoChip custom genotyping array, we analyzed 14,498 subjects with multiple sclerosis an...
Using the ImmunoChip custom genotyping array, we analyzed 14,498 subjects with multiple sclerosis an...
Background: Multiple sclerosis (MS) is the most common cause of chronic neurologic disability beginn...
Using the ImmunoChip custom genotyping array, we analyzed 14,498 subjects with multiple sclerosis an...
Using the ImmunoChip custom genotyping array, we analyzed 14,498 subjects with multiple sclerosis an...
We investigated the association between 52 risk variants identified through genome-wide association ...
We investigated the association between 52 risk variants identified through genome-wide association ...
ObjectiveWe investigated the association between 52 risk variants identified through genome-wide ass...
OBJECTIVE: We investigated the association between 52 risk variants identified through genome-wide ...
A recent genome wide association study (GWAS) demonstrated that more than 100 genetic variants influ...
A recent genome wide association study (GWAS) demonstrated that more than 100 genetic variants influ...
A previous study using cumulative genetic risk estimations in multiple sclerosis (MS) successfully t...
A previous study using cumulative genetic risk estimations in multiple sclerosis (MS) successfully t...
Using the ImmunoChip custom genotyping array, we analyzed 14,498 subjects with multiple sclerosis an...
Background: Multiple sclerosis (MS) is the most common cause of chronic neurologic disability beginn...
Using the ImmunoChip custom genotyping array, we analyzed 14,498 subjects with multiple sclerosis an...
Using the ImmunoChip custom genotyping array, we analyzed 14,498 subjects with multiple sclerosis an...
Background: Multiple sclerosis (MS) is the most common cause of chronic neurologic disability beginn...
Using the ImmunoChip custom genotyping array, we analyzed 14,498 subjects with multiple sclerosis an...
Using the ImmunoChip custom genotyping array, we analyzed 14,498 subjects with multiple sclerosis an...